QI
HZNP

Qtron Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Qtron Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,218
Closed -$252K – 459
2022
Q4 		$252K Buy
+2,218
New +$184K 0.05% 372
2022
Q3 		– Sell
-8,030
Closed -$640K – 456
2022
Q2 		$640K Hold
8,030
– – 0.14% 203
2022
Q1 		$845K Hold
8,030
– – 0.19% 148
2021
Q4 		$865K Sell
8,030
-883
-10% -$96.3K 0.2% 162
2021
Q3 		$976K Buy
8,913
+4,531
+103% +$470K 0.26% 104
2021
Q2 		$410K Hold
4,382
– – 0.1% 238
2021
Q1 		$403K Sell
4,382
-1,634
-27% -$138K 0.11% 224
2020
Q4 		$440K Hold
6,016
– – 0.12% 210
2020
Q3 		$467K Buy
6,016
+1,190
+25% +$81.9K 0.16% 150
2020
Q2 		$268K Sell
4,826
-1,989
-29% -$85.1K 0.11% 216
2020
Q1 		$202K Sell
6,815
-5,459
-44% -$185K 0.12% 209
2019
Q4 		$444K Hold
12,274
– – 0.26% 129
2019
Q3 		$334K Hold
12,274
– – 0.2% 148
2019
Q2 		$295K Hold
12,274
– – 0.18% 181
2019
Q1 		$324K Hold
12,274
– – 0.3% 99
2018
Q4 		$240K Buy
+12,274
New +$241K 0.18% 138

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Qtron Investments's HZNP Position: Q1 2023 in Review

Qtron Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 2,218 shares — an estimated $252K sold.

Qtron Investments first reported a position in HZNP in Q4 2018 and held it in 16 quarters. The position peaked at $976K in Q3 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

  • Qtron Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Qtron Investments sold 2,218 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $252K.
  • Qtron Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2018 and held it in 16 quarters.
  • Qtron Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $976K in Q3 2021.
  • 553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Qtron Investments's 13F filing for Q1 2023, filed 11 May 2023.